Global Markets Direct Market Research Reports

Sort By :

Title	Published	Price
Acute Promyelocytic Leukemia – Pipeline Review, H1 2012 *By Global Markets Direct* Acute Promyelocytic Leukemia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Acute Promyelocytic Leukemia - Pipeline Review, H1 2012'', provides an overview of the Acute Promyelocytic Leukemia therapeutic pipeline. This report provi	June 2012	$ 500
Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012 *By Global Markets Direct* Meningococcemia (Meningococcal Infections) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2012'', provides an overview of the Meningococcemia (Meningococcal Infection	June 2012	$ 500
Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012 *By Global Markets Direct* Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2012'', provides an overview of the Streptococcus Pneumoniae	June 2012	$ 500
Diabetic Neuropathic Pain – Pipeline Review, H1 2012 *By Global Markets Direct* Diabetic Neuropathic Pain – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Diabetic Neuropathic Pain - Pipeline Review, H1 2012'', provides an overview of the Diabetic Neuropathic Pain therapeutic pipeline. This report provides infor	June 2012	$ 500
Premature Labor (Tocolysis) – Pipeline Review, H1 2012 *By Global Markets Direct* Premature Labor (Tocolysis) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Premature Labor (Tocolysis) - Pipeline Review, H1 2012'', provides an overview of the Premature Labor (Tocolysis) therapeutic pipeline. This report provides	June 2012	$ 500
Wilms' Tumor (Nephroblastoma) – Pipeline Review, H1 2012 *By Global Markets Direct* Wilms'' Tumor (Nephroblastoma) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Wilms'' Tumor (Nephroblastoma) - Pipeline Review, H1 2012'', provides an overview of the Wilms'' Tumor (Nephroblastoma) therapeutic pipeline. This report pr	June 2012	$ 500
Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012 *By Global Markets Direct* Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2012'', provides an overview of the Dry (Atrophic) Macular Degeneration therapeutic pipeli	June 2012	$ 500
Chondrosarcoma – Pipeline Review, H1 2012 *By Global Markets Direct* Chondrosarcoma – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Chondrosarcoma - Pipeline Review, H1 2012'', provides an overview of the Chondrosarcoma therapeutic pipeline. This report provides information on the therapeutic develop	June 2012	$ 500
Cellulitis – Pipeline Review, H1 2012 *By Global Markets Direct* Cellulitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Cellulitis - Pipeline Review, H1 2012'', provides an overview of the Cellulitis therapeutic pipeline. This report provides information on the therapeutic development for Cel	June 2012	$ 500
Left Ventricular Dysfunction – Pipeline Review, H1 2012 *By Global Markets Direct* Left Ventricular Dysfunction – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Left Ventricular Dysfunction - Pipeline Review, H1 2012'', provides an overview of the Left Ventricular Dysfunction therapeutic pipeline. This report provi	June 2012	$ 500
Obstructive Sleep Apnea – Pipeline Review, H1 2012 *By Global Markets Direct* Obstructive Sleep Apnea – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Obstructive Sleep Apnea - Pipeline Review, H1 2012'', provides an overview of the Obstructive Sleep Apnea therapeutic pipeline. This report provides information	June 2012	$ 500
Eosinophilic Esophagitis – Pipeline Review, H1 2012 *By Global Markets Direct* Eosinophilic Esophagitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Eosinophilic Esophagitis - Pipeline Review, H1 2012'', provides an overview of the Eosinophilic Esophagitis therapeutic pipeline. This report provides informat	June 2012	$ 500
Microalbuminuria – Pipeline Review, H1 2012 *By Global Markets Direct* Microalbuminuria – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Microalbuminuria - Pipeline Review, H1 2012'', provides an overview of the Microalbuminuria therapeutic pipeline. This report provides information on the therapeutic d	June 2012	$ 500
Venous Leg Ulcers – Pipeline Review, H1 2012 *By Global Markets Direct* Venous Leg Ulcers – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Venous Leg Ulcers - Pipeline Review, H1 2012'', provides an overview of the Venous Leg Ulcers therapeutic pipeline. This report provides information on the therapeuti	June 2012	$ 500
General Anxiety Disorder – Pipeline Review, H1 2012 *By Global Markets Direct* General Anxiety Disorder – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''General Anxiety Disorder - Pipeline Review, H1 2012'', provides an overview of the General Anxiety Disorder therapeutic pipeline. This report provides informat	June 2012	$ 500
Brain Injury – Pipeline Review, H1 2012 *By Global Markets Direct* Brain Injury – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Brain Injury - Pipeline Review, H1 2012'', provides an overview of the Brain Injury therapeutic pipeline. This report provides information on the therapeutic development f	June 2012	$ 500
Dilated Cardiomyopathy – Pipeline Review, H1 2012 *By Global Markets Direct* Dilated Cardiomyopathy – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Dilated Cardiomyopathy - Pipeline Review, H1 2012'', provides an overview of the Dilated Cardiomyopathy therapeutic pipeline. This report provides information on	June 2012	$ 500
Lymphoblastic Lymphoma – Pipeline Review, H1 2012 *By Global Markets Direct* Lymphoblastic Lymphoma – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Lymphoblastic Lymphoma - Pipeline Review, H1 2012'', provides an overview of the Lymphoblastic Lymphoma therapeutic pipeline. This report provides information on	June 2012	$ 500
Pancreatitis – Pipeline Review, H1 2012 *By Global Markets Direct* Pancreatitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Pancreatitis - Pipeline Review, H1 2012'', provides an overview of the Pancreatitis therapeutic pipeline. This report provides information on the therapeutic development f	June 2012	$ 500
Gastric Ulcers – Pipeline Review, H1 2012 *By Global Markets Direct* Gastric Ulcers – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Gastric Ulcers - Pipeline Review, H1 2012'', provides an overview of the Gastric Ulcers therapeutic pipeline. This report provides information on the therapeutic develop	June 2012	$ 500
Corneal Neovascularization – Pipeline Review, H1 2012 *By Global Markets Direct* Corneal Neovascularization – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Corneal Neovascularization - Pipeline Review, H1 2012'', provides an overview of the Corneal Neovascularization therapeutic pipeline. This report provides in	June 2012	$ 500
Meningioma – Pipeline Review, H1 2012 *By Global Markets Direct* Meningioma – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Meningioma - Pipeline Review, H1 2012'', provides an overview of the Meningioma therapeutic pipeline. This report provides information on the therapeutic development for Men	June 2012	$ 500
Herpes Infections – Pipeline Review, H1 2012 *By Global Markets Direct* Herpes Infections – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Herpes Infections - Pipeline Review, H1 2012'', provides an overview of the Herpes Infections therapeutic pipeline. This report provides information on the therapeuti	June 2012	$ 500
House Dust Mite Allergy – Pipeline Review, H1 2012 *By Global Markets Direct* House Dust Mite Allergy – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''House Dust Mite Allergy - Pipeline Review, H1 2012'', provides an overview of the House Dust Mite Allergy therapeutic pipeline. This report provides information	June 2012	$ 500
Emesis (Vomiting) – Pipeline Review, H1 2012 *By Global Markets Direct* Emesis (Vomiting) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Emesis (Vomiting) - Pipeline Review, H1 2012'', provides an overview of the Emesis (Vomiting) therapeutic pipeline. This report provides information on the therapeuti	June 2012	$ 500
Malignant Pleural Effusion – Pipeline Review, H1 2012 *By Global Markets Direct* Malignant Pleural Effusion – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Malignant Pleural Effusion - Pipeline Review, H1 2012'', provides an overview of the Malignant Pleural Effusion therapeutic pipeline. This report provides in	June 2012	$ 500
Primary Sclerosing Cholangitis – Pipeline Review, H1 2012 *By Global Markets Direct* Primary Sclerosing Cholangitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Primary Sclerosing Cholangitis - Pipeline Review, H1 2012'', provides an overview of the Primary Sclerosing Cholangitis therapeutic pipeline. This report	June 2012	$ 500
Dyspnea – Pipeline Review, H1 2012 *By Global Markets Direct* Dyspnea – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Dyspnea - Pipeline Review, H1 2012'', provides an overview of the Dyspnea therapeutic pipeline. This report provides information on the therapeutic development for Dyspnea, com	June 2012	$ 500
Dental Pain – Pipeline Review, H1 2012 *By Global Markets Direct* Dental Pain – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Dental Pain - Pipeline Review, H1 2012'', provides an overview of the Dental Pain therapeutic pipeline. This report provides information on the therapeutic development for	June 2012	$ 500
Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012 *By Global Markets Direct* Circadian Rhythm Sleep Disorders – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Circadian Rhythm Sleep Disorders - Pipeline Review, H1 2012'', provides an overview of the Circadian Rhythm Sleep Disorders therapeutic pipeline. This	June 2012	$ 500
Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012 *By Global Markets Direct* Bacterial (Pyogenic) Meningitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Bacterial (Pyogenic) Meningitis - Pipeline Review, H1 2012'', provides an overview of the Bacterial (Pyogenic) Meningitis therapeutic pipeline. This rep	June 2012	$ 500
Kawasaki Disease – Pipeline Review, H1 2012 *By Global Markets Direct* Kawasaki Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Kawasaki Disease - Pipeline Review, H1 2012'', provides an overview of the Kawasaki Disease therapeutic pipeline. This report provides information on the therapeutic d	June 2012	$ 500
Retinopathy – Pipeline Review, H1 2012 *By Global Markets Direct* Retinopathy – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Retinopathy - Pipeline Review, H1 2012'', provides an overview of the Retinopathy therapeutic pipeline. This report provides information on the therapeutic development for	June 2012	$ 500
Patent Ductus Arteriosus – Pipeline Review, H1 2012 *By Global Markets Direct* Patent Ductus Arteriosus – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Patent Ductus Arteriosus - Pipeline Review, H1 2012'', provides an overview of the Patent Ductus Arteriosus therapeutic pipeline. This report provides informat	June 2012	$ 500
Yellow Fever – Pipeline Review, H1 2012 *By Global Markets Direct* Yellow Fever – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Yellow Fever - Pipeline Review, H1 2012'', provides an overview of the Yellow Fever therapeutic pipeline. This report provides information on the therapeutic development f	June 2012	$ 500
Cat Allergy – Pipeline Review, H1 2012 *By Global Markets Direct* Cat Allergy – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Cat Allergy - Pipeline Review, H1 2012'', provides an overview of the Cat Allergy therapeutic pipeline. This report provides information on the therapeutic development for	June 2012	$ 500
Lymphangioleiomyomatosis – Pipeline Review, H1 2012 *By Global Markets Direct* Lymphangioleiomyomatosis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Lymphangioleiomyomatosis - Pipeline Review, H1 2012'', provides an overview of the Lymphangioleiomyomatosis therapeutic pipeline. This report provides informat	June 2012	$ 500
Cholera – Pipeline Review, H1 2012 *By Global Markets Direct* Cholera – Pipeline Review, H1 2012 Summary Global Markets Direct’s, ''Cholera - Pipeline Review, H1 2012'', provides an overview of the Cholera therapeutic pipeline. This report provides information on the therapeutic development for Cholera, com	June 2012	$ 500
Acute Spinal Cord Injury – Pipeline Review, H1 2012 *By Global Markets Direct* Acute Spinal Cord Injury – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Acute Spinal Cord Injury - Pipeline Review, H1 2012', provides an overview of the Acute Spinal Cord Injury therapeutic pipeline. This report provides informat	April 2012	$ 500
Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2012 *By Global Markets Direct* Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2012', provides an overview of the Post-Traumatic Stress Disorder (PTSD) therapeutic	April 2012	$ 500
Post Menopausal Osteoporosis – Pipeline Review, H1 2012 *By Global Markets Direct* Post Menopausal Osteoporosis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Post Menopausal Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Post Menopausal Osteoporosis therapeutic pipeline. This report provi	April 2012	$ 500
Nausea – Pipeline Review, H1 2012 *By Global Markets Direct* Nausea – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Nausea - Pipeline Review, H1 2012', provides an overview of the Nausea therapeutic pipeline. This report provides information on the therapeutic development for Nausea, complet	April 2012	$ 500
Hyperlipidemia – Pipeline Review, H1 2012 *By Global Markets Direct* Hyperlipidemia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Hyperlipidemia - Pipeline Review, H1 2012', provides an overview of the Hyperlipidemia therapeutic pipeline. This report provides information on the therapeutic develop	April 2012	$ 500
Pulmonary Arterial Hypertension – Pipeline Review, H1 2012 *By Global Markets Direct* Pulmonary Arterial Hypertension – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, H1 2012', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This rep	April 2012	$ 500
Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H1 2012 *By Global Markets Direct* Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2012', provides an overview of the Interstitial Cystitis (Painf	April 2012	$ 500
Pemphigus Vulgaris – Pipeline Review, H1 2012 *By Global Markets Direct* Pemphigus Vulgaris – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Pemphigus Vulgaris - Pipeline Review, H1 2012', provides an overview of the Pemphigus Vulgaris therapeutic pipeline. This report provides information on the therape	April 2012	$ 500
Athlete's Foot (Tinea Pedis) – Pipeline Review, H1 2012 *By Global Markets Direct* Athlete's Foot (Tinea Pedis) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2012', provides an overview of the Athlete's Foot (Tinea Pedis) therapeutic pipeline. This report provi	April 2012	$ 500
Hyponatremia – Pipeline Review, H1 2012 *By Global Markets Direct* Hyponatremia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Hyponatremia - Pipeline Review, H1 2012', provides an overview of the Hyponatremia therapeutic pipeline. This report provides information on the therapeutic development f	April 2012	$ 500
Vitiligo – Pipeline Review, H1 2012 *By Global Markets Direct* Vitiligo – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Vitiligo - Pipeline Review, H1 2012', provides an overview of the Vitiligo therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo,	April 2012	$ 500
Pruritus – Pipeline Review, H1 2012 *By Global Markets Direct* Pruritus – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Pruritus - Pipeline Review, H1 2012', provides an overview of the Pruritus therapeutic pipeline. This report provides information on the therapeutic development for Pruritus,	April 2012	$ 500

First

Last

Search for Market Research Reports:

Home › Publisher › Global Markets Direct

Global Markets Direct Market Research Reports

Start New Browse